申请人:Glaxo Wellcome Inc.
公开号:US05981572A1
公开(公告)日:1999-11-09
The invention thus provides compounds of Formula (I) ##STR1## wherein R.sup.1 and R.sup.2 which may be the same or different represent H, C.sub.1-6 alkyl or substituted alkyl or C.sub.3-7 cycloalkyl; or aryl; R.sup.3, and R.sup.4 which may be the same or different represent H, halogen, C.sub.1-6 alkyl; or substituted aryl; R.sup.5 is H or C.sub.1-6 alkyl; n is an integer 0, 1 or 2 and m is an integer 1, 2, 3, or 4; the dotted line indicates the presence or absence of an additional bond; and pharmaceutically acceptable solvates (e.g. hydrates) thereof.
该发明提供了Formula (I)的化合物,其中R.sup.1和R.sup.2(可以相同也可以不同)代表H、C.sub.1-6烷基或取代烷基或C.sub.3-7环烷基;或芳基;R.sup.3和R.sup.4(可以相同也可以不同)代表H、卤素、C.sub.1-6烷基;或取代芳基;R.sup.5为H或C.sub.1-6烷基;n为整数0、1或2,m为整数1、2、3或4;虚线表示存在或不存在额外的键;以及其药学上可接受的溶剂化合物(例如水合物)。